![]() |
| Kathryn Hackman. See more |
| Jay Jha. See more |
![]() |
| Kathryn Hackman. See more |
| Jay Jha. See more |
Congratulations to two of our PhD students who have recently been awarded their degrees.
Andris Ellims
The purpose of this study is to investigate the use of the medication Ondansetron as an adjunctive or add-on therapy to existing anti-psychotic medication in the treatment of schizophrenia symptoms. Ondansetron is a well established medication which is approved in Australia for the treatment of drug-induced nausea and vomiting. However, various case studies and clinical studies have shown Ondansetron to also be effective in the treatment of symptoms associated with persistent schizophrenia.